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Background: About eighty percent of acute myocardial infarction (AMI) cases occur in the elderly, we aim to
examine the use of reperfusion strategies in elderly patients (≥65 years) with AMI and to investigate the factors
affecting the use of these strategies.
Methods: A total of 352 consecutive elderly patients (≥65 years) with ST-elevated AMI (STAMI) were admitted, they
were divided into 2 groups based on reperfusion treatment (thrombolysis or percutaneous coronary intervention,
PCI): reperfusion therapy group (n = 268) and non-reperfusion therapy group (n = 84). Demographic and medical
data were collected for comparison. Odds ratios (OR) and 95% confidence interval (C.I.) were calculated directly
from the estimated regression coefficients.
Results: About 76.1% of the elderly patients with AMI received reperfusion treatment (62.5% received PCI, and
13.6% received thrombolysis). Stepwise Logistic regression analysis revealed that a patient age ≥75 years (95%
CI: 0.194 ~ 0.590, OR = 0.338, P = 0.000) and medical history of angina (95% CI: 0.281 ~ 0.928, OR = 0.501, P = 0.014)
were determining factors for receiving less reperfusion therapy. Complications including right ventricular myocardial
infarction (MI) (95% CI: 1.618 ~ 12.907, OR = 4.472, P = 0.003), unbearable symptoms (95% CI: 1.132 ~ 3.928, OR = 1.839,
P = 0.021) and medical insurance (95% CI: 1.313 ~ 4.524, OR = 2.429, P = 0.004) were independent predictors of
reperfusion therapy. The reperfusion therapy subset analysis revealed that intracranial hemorrhage (2.7% vs. 8.3%,
P = 0.000), left ventricular ejection fraction (LVEF) <45% (13.2% vs. 29.2%, P = 0.019) and mortality rate within 1 year
(2.7% vs. 6.3%, P = 0.045) were significantly decreased in the PCI group as compared with thrombolysis.
Conclusion: Elderly patients with a medical history of angina, right ventricular MI, unbearable symptoms and medical
insurance are likely be recipients of reperfusion strategies.
Keyword: Acute myocardial infarction, Elderly, Percutaneous coronary intervention, Thrombolysis, Influencing factorsBackground
Acute myocardial infarction (AMI) or ‘heart attack’ is
one of the top ten leading causes of death worldwide [1],
about eighty percent of AMI cases occur in the elderly
[2]. Therefore, a clinically relevant research for coronary
heart disease in elderly patients is needed, especially for
those with ST-elevated myocardial infarction (STEMI).
STEMI, resulted from a rupture of coronary artery plaque
followed by a thrombosis, could cause acute coronary
artery blockages and flow interruption.
Effective and continued opening of the infarct related
artery (IRA) is crucial to protecting left ventricular function* Correspondence: wangxianscience@163.com
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Reperfusion therapy, including thrombolytic therapy and
percutaneous coronary intervention (PCI), is effective
in reducing the mortality rate of STEMI patients [5,6].
However, many elderly patients with AMI do not receive
reperfusion therapy in a timely and effective manner. The
purpose of this study was to survey the present situation
of elderly patients with AMI in the Beijing area who ac-
cepted reperfusion therapy and to discuss the predictors
of the reception of reperfusion therapy.Methods
Patients
The study has been approved and registered by Beijing
military general hospital in January 2005, the Ethicshis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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data collection of these patients, all subjects signed writ-
ten informed consent form. All works were undertaken
following the provisions of the Declaration of Helsinki.
The prospective survey-included patients consisted of
352 consecutive cases of elderly patients with STEMI
(≥65 years) who were admitted to the coronary care unit
of the Beijing military general hospital from February
2005 to February 2009.
These patients were divided into 2 groups based on
their reception of reperfusion (thrombolysis or PCI)
strategies: reperfusion therapy group (n = 268) and
non-reperfusion therapy group (n = 84). The inclusion
criteria were (1) the patient was ≥ 65 years of age; (2)
the patient was admitted into the hospital within 24 h
of MI symptoms that meet the diagnostic criteria of
AMI [7,8], including continued chest pain over 30 min;
an elevated ST-segment over 2 mm in at least two con-
tinuous precardial leads or over 1 mm in at least two
continuous limb leads (II, III, aVF); and serum creatine
kinase isoenzymes (CK-MB) levels double that of the
normal or upper limit; and (3) the patient provided
written informed consent for the study. The exclusion
criteria were (1) AMI occurred after admission for
other diseases; (2) the clinical state of the patient did
not allow for inclusion, as decided by a physician; and
(3) the patient did not agree to participate in the study.
Data collection
Investigators in the study were given uniform training in
filling out the survey form. The survey contents included
(1) basic clinical characteristics including their age, gender,
marital status, education level, income, health insurance,
cardiovascular risk factor and cardiovascular health his-
tory; (2) onset background factors, including ① location:
either at home or elsewhere; ② time: daytime was re-
ferred to as 6:01 ~ 19:59 and nighttime was referred to
as 20:00 ~ 6:00; and ③ whether anyone else was present
during the attack; (3) Symptoms; (4) time period from the
onset of symptoms to admission; and (5) type of reperfu-
sion therapy (thrombolysis or PCI).
Statistical analysis
Data were all analyzed using SPSS 11.5statistics software.
Quantifiable data between the 2 groups were compared
using Chi-square tests; double tests were adopted in all
tests of statistically significant differences, and P < 0.05
was used to determine statistical significance. The various
related factors affecting reperfusion therapy in the patients
were analyzed by a Logistic regression analysis of multiple
factors (Forwald: Conditional method). Single factor ana-
lysis was performed on variables meaningful for regression
analysis or significantly influencing reperfusion therapy,




Comparisons of social population data, risk factors and
background between the 2 groups
The social population data, risk factors, medical history
and attack background of 2 groups were collected in
Table 1. As we can see, most of the patients in the
non-reperfusion therapy group was elderly (77 ± 7 vs.
73 ± 5 years, P = 0.000) and had a history of angina
(OR = 0.492, P = 0.006). Most of the patients in the reper-
fusion therapy group had medical insurance (OR = 2.393,
P = 0.002), high incomes (OR = 1.521, P = 0.032) and a
well-educated background (OR = 1.424, P = 0.049).
Comparisons of symptom types and clinical characteristics
between the 2 groups
The symptom types and clinical characteristics of the
two patient groups were collected in Table 2. Most of
the patients in reperfusion therapy group have unbear-
able symptoms (OR = 2.272, P = 0.002), polypnea (OR =
0.530, P = 0.036) and excessive perspiration (OR = 1.891,
P = 0.021).
Multivariable analyses of the factors influencing reception
of reperfusion therapy in elderly patients with AMI
Results showed that five factors, including age (OR =
0.338, P = 0.000), a history of angina (OR = 0.501, P =
0.014), right ventricle MI (OR = 4.472, P =0.003), unbear-
able symptoms (OR = 1.839, P =0.021), medical insurance
(OR = 2.429, P =0.004) were statistically significance in
predicating whether the patients of AMI received re-
perfusion therapy (Table 3).
Reperfusion therapy subset analysis
The patients were divided into 2 subgroups based on the
reception of reperfusion therapy methods: PCI (n = 220)
and thrombolysis (n = 48) groups. Results showed the
intracranial hemorrhage (2.7% vs 8.3%, P = 0.000), left ven-
tricular ejection fraction (LVEF) < 45% (13.2% vs 29.2%,
P = 0.019) and mortality rate within 1 year (2.7% vs
6.3%, P = 0.045) were significantly decreased in the PCI
group as compared with the thrombolysis group (Table 4).
Nonfatal MI (P = 0.292) and revascularization (P = 0.239)
showed no statistically significant difference between the
PCI and thrombolysis groups.
Discussion
Recently, the American College of Cardiology/American
Heart Association (ACC/AHA) and European Society of
Cardiology (ESC) guidelines revealed that thrombolysis
was at least as effective as balloon dilation for patients
Table 1 Demographic characteristics of patients in the reperfusion therapy (RTG) group and non RTG group
Variables RTG group (n = 268), n (%) Non RTG group (n = 84), n (%) P values OR values 95% C.I.
Social descriptive variables
Ages (mean ± SD,years) 73 ± 5 77 ± 7 0.000
Female 91(34.0%) 33(39.2%) 0.246 0.747 0.446-1.229
Married 221(82.5%) 59(70.2%) 0.004 2.383 1.332-4.268
Education level 0.049 1.424 1.007-1.946
Primary school 115(42.9%) 45(53.6%)
Middle school 55( 20.5%) 15(17.9%)
Undergraduate/graduate 98(36.8%) 24(28.6%)
Salaries (RMB/ month) 0.032 1.521 1.038-2.358
<500 31(11.6%) 21(25.0%)
500 ~ 2000 153(57.1%) 43(51.2%)
2000 ~ 5000 70(26.1%) 16(19.0%)
>5000 14(5.2%) 4(4.8%)
Medical insurance 218(81.3%) 55(65.5%) 0.002 2.393 1.427-4.397
Being professionally trained 38(14.2%) 8(9.5%) 0.091 2.251 0.831-5.416
Cardiovascular risk factors
Hypertension 160(59.7%) 58(69.0%) 0.226 0.636 0.419-1.092
Diabetes 63(23.5%) 25(29.8%) 0.398 0.740 0.432-1.299
Hyperlipemia 59(22.0%) 18(21.4%) 0.860 0.992 0.529-1.820
Family history of coronary artery disease 19(7.1%) 3(3.6%) 0.229 2.570 0.551-12.203
Smoking 101(37.7%) 20(23.8%) 0.062 1.812 0.992-3.021
Medical histories
MI, myocardial infarction 28(10.4%) 11(13.1%) 0.098 0.623 0.276-1.214
Angina 83(31.0%) 34(40.5%) 0.006 0.492 0.299-0.874
CHF, Chronic heart failure 16(5.6%) 4(4.8%) 0.289 0.508 0.132-1.892
Stroke 41(15.3%) 15(17.9%) 0.231 0.696 0.368-1.321
Backgrounds of MI
Attack at night 89(33.2%) 32(38.1%) 0.261 0.794 0.456-1.902
Attack at home 231(86.2%) 73(86.9%) 0.872 1.069 0.452-2.349
Persons present at onset 222(82.8%) 71(84.5%) 0.325 1.419 0.781-2.283
Emergency medical services 128(47.8%) 42(50.0%) 0.568 1.119 0.730-1.952
ECG outside of hospital 118(44.0%) 34(40.5%) 0.258 1.302 0.817-2.354
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tween admission and balloon dilation was over 90 min
[9-11]. Therefore, it was of extreme significance for pa-
tients with AMI to receive timely and effective reperfu-
sion therapy, which includes either thrombolysis or PCI.
However, the current status of the reception of reperfu-
sion therapy in elderly patients with AMI in China is
unsatisfactory.
Single factor analysis of social population material,
risk factors, medical history, attack background factors,
symptom type and other clinical characteristics revealed
in this study show that most of the patients in thenon-reperfusion therapy group were elderly (77 ± 7 vs
73 ± 5 years on an average, P < 0.001) and had a history
of angina (OR = 0.591, P = 0.014). For patients over
80 years of age, thrombolytic therapy is indeed risky;
but PCI, when performed by an experienced operator
in a catheterization room, is one of the most effective
measures for opening infarction associated vessels, and is
a vital therapy for protecting the cardiac function and
improving the survival rate of elderly patients with
AMI. Some patients with a history of angina do not re-
ceive effective reperfusion therapy because (1) these
patients were accustomed to the onset of chest pain
Table 2 Comparisons of symptom types and clinical characteristics between RTG and non RTG patients
Variables RTG group
(n = 268), n (%)
Non RTG group
(n = 84), n (%)
P values OR values 95% C.I.
Symptom types
Chest pain 227 (84.7%) 68 (81.0%) 0.261 1.461 0.754-2.981
Vomiting 116 (43.3%) 27 (32.1%) 0.191 1.447 0.891-2.420
Fears 48 (17.9%) 12 (14.3%) 0.616 1.272 0.689-2.989
Unbearable symptoms 198 (73.9%) 46 (54.8%) 0.002 2.272 1.322-3.694
Polypnea 49 (18.3%) 22 (26.2%) 0.036 0.530 0.291-0.983
Excessive perspiration 198 (73.9%) 50 (59.5%) 0.021 1.891 1.121-3.219
Clinical characteristics
Antetheca MI 139 (51.9%) 50 (59.5%) 0.367 1.364 0.869-2.292
Right ventricle MI 60 (22.4%) 4 (4.8%) 0.000 4.615 1.692-11.234
Klliip ≥2 levels 49 (18.3%) 15 (17.9%) 0.366 0.921 0.737-1.311
Years of age ≥75 132 (49.3%) 55 (65.5%) 0.000 0.318 0.297-0.641
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symptoms or (2) symptoms of angina masked those of
AMI, which is especially common in patients with diabetes.
Most of the patients in the reperfusion therapy group had
medical insurance (OR = 2.429, P = 0.004), higher economic
income, (OR = 1.521, P = 0.032) and a well-educated back-
ground (OR = 1.424, P = 0.049). Patients with medical
insurance and higher income could receive timely and
effective reperfusion therapy, suggesting whether the
capacity for timely payment of medical expenses was
also a factor affecting the reception of reperfusion ther-
apy in elderly patients with AMI. This finding could po-
tentially have an impact on medical insurance systems
for the management of elderly patients with AMI. Well
educated elderly patients with AMI could receive more
effective reperfusion therapy because (1) they realized at
once that AMI had occurred and that their lives were in
danger; or (2) they were aware that PCI treatment of
coronary heart disease had the ability to effectively open
coronary artery infarctions. Therefore, popularization of
coronary heart disease to improve public understanding
of different types of reperfusion therapy, such as PCI, is
of great significance.Table 3 Multivariable analyses of factors affecting the
reception of reperfusion therapy in elderly patients with
AMI
Variables Β values P values OR values 95% C.I.
Years of age ≥75 −1.252 0.000 0.338 0.194-0.590
History of angina −0.697 0.014 0.501 0.281-0.928
Right ventricle MI 1.523 0.003 4.472 1.618-12.907
Unbearable symptoms 0.623 0.021 1.839 1.132-3.928
Medical insurance 0.882 0.004 2.429 1.313-4.524Elderly patients with AMI who exhibited onset symp-
toms such as excessive perspiration (OR = 2.272, P =
0.002), dyspnea (OR = 0.530, P = 0.036) and unbearable
symptoms (OR = 1.891, P = 0.021) were more likely to
receive reperfusion therapy; This was likely related to a
realization of the severity and life-threatening nature of
their symptoms. The multi-factor analysis showed that
five factors, consisting of age, a history of angina, right
ventricular MI, unbearable symptoms and medical in-
surance, were independent predictors of the reception
of reperfusion therapy. Patients with AMI, older than
75 years of age with a history of angina, were less likely
to receive reperfusion therapy, while those with right
ventricular MI, unbearable symptoms and medical in-
surance were more likely to receive therapy.
Additionally, this study did not show a statistically
significant difference (OR = 1.119, P = 0.568) in alert-
ing Emergency Medical Services (EMS) between the
two groups; however, the importance of EMS should
be emphasized in the treatment of elderly patients
with AMI. EMS offer potential advantages toward re-
ducing mortality: (1) EMS can implement life support
in the case of cardiac arrest outside of the hospital.
In the United Kingdom Heart Attack Study (UKHAS),
among the 1829 cases of EMS-transported patients,
111 cases were resuscitated successfully by aid workers
and 74% of the patients were diagnosed with ventricular
tachycardia or fibrillation [12]. (2) EMS can transport pa-
tients to a hospital capable of reperfusion therapy rapidly;
(3) EMS can perform electrocardiographic (ECG) examin-
ation and offer a diagnosis on the spot, which is significant
for reducing pre-hospital delays; (4) EMS can inform doc-
tors and nurses in the emergency room or catheterization
room while in transit; and (5) a well-equipped EMS can
carry out the thrombolytic therapy at the home of the
Table 4 Reperfusion therapy subset analyses in elderly patients with AMI
Variables PCI group (n = 220) Thrombolysis group (n = 48) P values
Ages (mean ± SD, yrs) 70.9 ± 4.32 69.7 ± 4.01 0.782
Males, n (%) 144 (65.5%) 33 (68.8%) 0.641
Cardiovascular risk factors, n (%)
Hypertension 131 (59.5%) 29 (60.4%) 0.279
Diabetes 52 (23.6%) 11 (22.9%) 0.321
Hyperlipidemia 51 (23.2%) 8 (16.7%) 0.417
Smoking 86 (39.1%) 15 (31.2%) 0.312
Medical histories, n (%)
MI 22 (10%) 6 (14%) 0.087
Chronic heart failure (CHF) 13 (5.9%) 3 (26%) 0.098
Stroke 31 (12.7%) 10 (20.8%) 0.059
Clinic events, n (%)
Intracranial hemorrhage 6 (2.7%) 4 (8.3%) 0.000
Nonfatal MI 19 (8.6%) 5 (10.4%) 0.292
Revascularization 25 (11.4%) 6 (12.5%) 0.239
LVEF < 45% 29 (13.2%) 14 (29.2%) 0.019
Mortality within 1 year 6 (2.7%) 3 (6.3%) 0.045
CABG = coronary arteries bypass grafting.
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that nosocomial mortality declines significantly for pre-
hospital thrombolytic patients [13].
Previous clinical trials have shown that thrombolysis
significantly increases fatal complications such as bleed-
ing, especially intracranial hemorrhage, and should not
be performed on elderly patients over 80 years of age
with STEMI [14]. Facilitated PCI was used to carry out
thrombolysis or combined anticoagulant therapy before
PCI, and was suspended because of the increased mor-
tality and bleeding complications in AMI patients. In re-
cent years, many clinical trials have shown that direct
PCI, especially with stents, was superior to thrombolytic
therapy for improving left ventricular function, reducing
the mortality rate within one year and reducing intracere-
bral hemorrhage for elderly patients with STEMI, as long
as reperfusion is performed within the golden period
window [15-17]. The fatality rate decreases signifi-
cantly for elderly patients with STEMI over 75 years of
age as a result of cardiogenic shock if direct PCI, aided
by a percutaneous intra-aortic balloon pump (IABP), is
performed [10].
The reperfusion therapy subset analysis in this study
revealed that intracranial hemorrhage (2.7% vs. 8.3%,
P = 0.000), LVEF < 45% (13.2% vs. 29.2%, P = 0.019) and
mortality rate within one year (2.7% vs. 6.3%, P = 0.045)
were significantly decreased in the PCI group, as com-
pared with thrombolysis. This trend was identical to those
reported in literature, suggesting that direct PCI issuperior to thrombolytic therapy for protecting left ven-
tricular function, reducing bleeding complications and im-
proving one year survival rates in elderly patients with
AMI.Conclusion
Direct PCI could become an important reperfusion method
for the treatment of elderly patients with STAMI with
continued improvements in equipment and increases in
the number of experienced physicians. However, more
studies with larger sample sizes are required to explain the
results presented in this paper.Abbreviation
ACC/AHA: American College of Cardiology/American Heart Association;
AMI: Acute myocardial infarction; C.I.: Confidence interval; CK-MB: Creatine
kinase isoenzymes; ECG: Electrocardiography; EMS: Emergency medical
services; ESC: European society of cardiology; IRA: Infarct related artery;
LVEF: Left ventricular ejection fraction; MI: Myocardial infarction; STEMI:
ST-elevated myocardial infarction; STAMI: ST-elevated acute myocardial
infarction; PCI: Percutaneous coronary intervention; OR: Odds ratios;
UKHAS: United Kingdom heart attack study.Competing interests
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